4391 - 4400 of 6295 Results
Title
Year
-
OPENTitle: Two distinct trajectories of clinical and neurodegeneration events in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00556-3Best OA location URL: https://www.nature.com/articles/s41531-023-00556-3.pdfCitation Count: 41
- Transient exposure to rotenone causes degeneration and progressive parkinsonian motor deficits, neuroinflammation, and synucleinopathy2023OPENTitle: Transient exposure to rotenone causes degeneration and progressive parkinsonian motor deficits, neuroinflammation, and synucleinopathyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00561-6Best OA location URL: https://www.nature.com/articles/s41531-023-00561-6.pdfCitation Count: 41
- Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson’s disease2023OPENTitle: Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00572-3Best OA location URL: https://www.nature.com/articles/s41531-023-00572-3.pdfCitation Count: 10
- Nerve growth factor receptor (Ngfr) induces neurogenic plasticity by suppressing reactive astroglial Lcn2/Slc22a17 signaling in Alzheimer’s disease2023OPENTitle: Nerve growth factor receptor (Ngfr) induces neurogenic plasticity by suppressing reactive astroglial Lcn2/Slc22a17 signaling in Alzheimer’s diseaseJournal Name: npj Regenerative MedicinePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41536-023-00311-5Best OA location URL: https://www.nature.com/articles/s41536-023-00311-5.pdfCitation Count: 19
- Antihypertensive drugs may not delay the symptom progression of Parkinson’s disease: A 2-year follow-up study2023OPENTitle: Antihypertensive drugs may not delay the symptom progression of Parkinson’s disease: A 2-year follow-up studyJournal Name: HeliyonPublisher: Elsevier BVVol: 9Issue #: 8Start Page: e18538End Page: e18538Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.heliyon.2023.e18538Best OA location URL: http://www.cell.com/article/S2405844023057468/pdfCitation Count: 0
- Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs – A model of sporadic Alzheimer’s disease2023OPENTitle: Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs – A model of sporadic Alzheimer’s diseaseJournal Name: HeliyonPublisher: Elsevier BVVol: 9Issue #: 8Start Page: e18443End Page: e18443Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.heliyon.2023.e18443Best OA location URL: https://doi.org/10.1016/j.heliyon.2023.e18443Citation Count: 2
- Environmental exposures and familial background alter the induction of neuropathology and inflammation after SARS-CoV-2 infection2025OPENTitle: Environmental exposures and familial background alter the induction of neuropathology and inflammation after SARS-CoV-2 infectionJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-025-00925-0Best OA location URL: https://www.nature.com/articles/s41531-025-00925-0.pdfCitation Count: 1
-
OPENTitle: Four questions to predict cognitive decline in de novo Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00958-5Best OA location URL: https://www.nature.com/articles/s41531-025-00958-5.pdfCitation Count: 0
-
OPENTitle: Genetic Testing for GBA and LRRK2 Mutations: Is it Time for Routine Use?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13619Best OA location URL: https://doi.org/10.1002/mdc3.13619Citation Count: 2
-
OPENTitle: Is Pathology Always the Diagnostic Gold Standard in Neurodegeneration?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 8Start Page: 1152End Page: 1153Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13570Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13570Citation Count: 5